Globus Medical Enjoys Another Solid Quarter Thanks to International Sales Growth

Globus Medical Enjoys Another Solid Quarter Thanks to International Sales Growth

So far, 2017 is shaping up to be the best year for Globus Medical (NYSE: GMED) shareholders in quite a while. The musculoskeletal implant manufacturer posted great numbers for the first quarter. Globus Medical stock has outperformed the broader market this year, despite a pullback over the last month.

This good track record was at risk, though, as Globus Medical announced its second-quarter results after the market closed on Wednesday. Globus didn't disappoint, however, turning in yet another solid performance. Here are the highlights. 

Image source: Getty Images.

Continue reading

Source: Fool.com